KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Abbott Laboratories (ABT) FCF Margin (2016 - 2025)

Abbott Laboratories (ABT) has disclosed FCF Margin for 17 consecutive years, with 22.92% as the latest value for Q4 2025.

  • Quarterly FCF Margin rose 334.0% to 22.92% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 16.68% through Dec 2025, up 154.0% year-over-year, with the annual reading at 16.68% for FY2025, 154.0% up from the prior year.
  • FCF Margin hit 22.92% in Q4 2025 for Abbott Laboratories, up from 20.15% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 22.92% in Q4 2025 to a low of 6.29% in Q1 2024.
  • Historically, FCF Margin has averaged 16.39% across 5 years, with a median of 17.52% in 2022.
  • Biggest five-year swings in FCF Margin: skyrocketed 1683bps in 2021 and later plummeted -1107bps in 2023.
  • Year by year, FCF Margin stood at 21.39% in 2021, then decreased by -20bps to 17.01% in 2022, then soared by 31bps to 22.29% in 2023, then dropped by -12bps to 19.57% in 2024, then grew by 17bps to 22.92% in 2025.
  • Business Quant data shows FCF Margin for ABT at 22.92% in Q4 2025, 20.15% in Q3 2025, and 13.87% in Q2 2025.